Page last updated: 2024-10-20

pyrazinamide and Agranulocytosis

pyrazinamide has been researched along with Agranulocytosis in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mühlberger, F1
Rabina, EV1
Semichastnova, AG1
Golubiatnikova, GA1

Other Studies

2 other studies available for pyrazinamide and Agranulocytosis

ArticleYear
[Allergy to antitubercular agents; with special reference to new drugs].
    Schweizerische medizinische Wochenschrift, 1973, Jan-27, Volume: 103, Issue:4

    Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hyp

1973
[Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
    Arkhiv patologii, 1972, Volume: 34, Issue:8

    Topics: Aged; Agranulocytosis; Antitubercular Agents; Carcinoma, Hepatocellular; Chemical and Drug Induced L

1972